• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Nancy Reau: COVID-19, Drinking Patterns, Lifestyle Factors Causing Increased Alcoholic Hepatitis Hospitalizations

Video

A combination of possible factors could be contributing to a recent uptick in hospitalizations for alcoholic cirrhosis of the liver, said Nancy Reau, MD, section chief of hepatology at Rush University Medical Center.

Nancy Reau, MD, section chief of hepatology at Rush University Medical Center, talks about what factors may have contributed to a recent uptick in hospitalizations for alcoholic cirrhosis of the liver.

Transcript

What contributed to the 23% increase in patient hospitalizations for alcoholic cirrhosis of the liver in the past year?

Alcoholic cirrhosis has definitely been increasing. We recognized this during the pandemic where one of the most frequent hospitalizations for a younger population was alcoholic hepatitis (AH). Unfortunately, when people present with [AH], a good proportion of them will already have established cirrhosis. This is especially true of those that have more severe [AH]. If your AH wasn't severe enough to lead to a hospitalization, you might recover more smoothly. If your AH led to a hospitalization, especially a prolonged one, then you are very likely to recover to cirrhosis. And then a person who has cirrhosis, you're more likely to have complications.

I think that part of this is the pandemic, part of it is pathologic drinking patterns, part of it is a combination of concomitant fatty liver and sedentary lifestyle, which definitely makes alcohol injury a little bit worse. And we are starting to see this peak as people start to be introspective and realize that unhealthy behaviors need to change. They still haven't leveled off, so we're seeing that uptick still in hospitalizations.

Related Videos
Dawn Klemow, MD, assistant clinical professor, The University of Texas Southwestern Medical Center
Jonathan Eisengart
Tiago Biachi, MD, PhD
Irina Dralyuk
Edgardo S. Santos, MD, FACP, FASCO
Irina Dralyuk
Keith Ferdinand, MD, professor of medicine and the Gerald S. Berenson Chair in Preventative Cardiology, Tulane University School of Medicine
Robin Glasco, Spencer Stuart
Edgardo S. Santos, MD, FACP, FASCO
Tiago Biachi, MD, PhD
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.